homovanillic acid has been researched along with Chorea in 21 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Chorea: Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We suggest that ceruletide may reduce choreic movement for a long period through effects on the central dopamine system and speculate that such a long-term effect may be accounted for by the change in transmission after the second messengers in neurons." | 6.67 | Acute reduction and long-term improvement of chorea with ceruletide (cholecystokinin analogue). ( Hashimoto, T; Yanagisawa, N, 1990) |
| "Homovanilic acid (HVA) was determined in the lumbar CSF of 12 patients with Huntington's disease and 12 with Sydenham's chorea before and after probenecid administration." | 3.66 | Homovanilic acid in Huntington's disease and Sydenham's chorea. ( Amaral, R; Conçalves, AF; Cunha, L; Diniz, M; Oliveira, CR; Pio-Abreu, J, 1981) |
| "We have studied the urinary excretion of 1,4-methylhistamine (1,4-MeHm), 5-hydroxyindole-3-acetic acid (5-HIAA) and homovanillic acid (HVA) in patients with Parkinson's disease, choreiform movements and essential tremor." | 3.65 | Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa. ( Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ, 1977) |
| "We suggest that ceruletide may reduce choreic movement for a long period through effects on the central dopamine system and speculate that such a long-term effect may be accounted for by the change in transmission after the second messengers in neurons." | 2.67 | Acute reduction and long-term improvement of chorea with ceruletide (cholecystokinin analogue). ( Hashimoto, T; Yanagisawa, N, 1990) |
| "Isoniazid was administered in 4-week open trial in patients with choreiform movement." | 1.27 | Isoniazid effects on choreiform movement and on GABA, HVA, and 5-HIAA in CSF. ( Kuroda, H; Ogawa, N; Otsuki, S; Yamamoto, M, 1983) |
| "When reserpine was discontinued, symptoms recurred." | 1.26 | Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially. ( Naidu, S; Narasimhachari, N, 1980) |
| "Patients with Huntington's chorea showed a low level of the HVA in the intraventricular fluid." | 1.26 | [Approaches to the study of dopamine metabolism in various extrapyramidal diseases]. ( Barkhatova, VP; Demina, EG; Kandel', EI, 1981) |
| "Treatment with tetrabenazine did not significantly alter the metabolite levels in patients in whom it produced either improvement, or side effects." | 1.26 | CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. ( Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM, 1977) |
| "Two male patients suffering from Sydenham's chorea were treated with a combination of L-Dopa and a peripheral decarboxylase inhibitor." | 1.25 | Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor. ( Corsini, GU; Mangoni, A; Marrosu, F; Spissu, A, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (95.24) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WILLIAMS, CM | 1 |
| MAURY, S | 1 |
| KIBLER, RF | 1 |
| SANKOFF, I | 1 |
| SOURKES, TL | 2 |
| Becker, RE | 1 |
| Lal, H | 1 |
| Naidu, S | 1 |
| Narasimhachari, N | 1 |
| Yamamoto, M | 2 |
| Otsuki, S | 2 |
| Kuroda, H | 1 |
| Ogawa, N | 1 |
| Miyake, K | 1 |
| Namba, R | 1 |
| Nagaraja, D | 1 |
| Srinivasa, R | 1 |
| Subhash, MN | 1 |
| Rao, BS | 1 |
| Cunha, L | 1 |
| Oliveira, CR | 1 |
| Diniz, M | 1 |
| Amaral, R | 1 |
| Conçalves, AF | 1 |
| Pio-Abreu, J | 1 |
| Barkhatova, VP | 1 |
| Kandel', EI | 1 |
| Demina, EG | 1 |
| Gray, MW | 1 |
| Herzberg, L | 1 |
| Lerman, JA | 1 |
| Turnbull, MJ | 2 |
| Victoratos, G | 1 |
| Chase, TN | 1 |
| Hochberg, Z | 1 |
| Davidson, DL | 1 |
| Yates, CM | 1 |
| Mawdsley, C | 1 |
| Pullar, IA | 1 |
| Wilson, H | 1 |
| Lenman, JA | 1 |
| Reid, A | 1 |
| Fleming, AM | 1 |
| Isgreen, WP | 1 |
| Chutorian, AM | 1 |
| Fahn, S | 1 |
| Lal, S | 1 |
| Allen, J | 1 |
| Etienne, P | 1 |
| Humphreys, P | 1 |
| McLellan, DL | 1 |
| Chalmers, RJ | 1 |
| Johnson, RH | 1 |
| Spissu, A | 1 |
| Corsini, GU | 1 |
| Marrosu, F | 1 |
| Mangoni, A | 1 |
| Hashimoto, T | 1 |
| Yanagisawa, N | 1 |
| Constantinidis, J | 1 |
| Guilleminault, C | 1 |
| Tharp, BR | 1 |
| Cousin, D | 1 |
1 review available for homovanillic acid and Chorea
| Article | Year |
|---|---|
Pharmacological approaches to treatment of hemiballism and hemichorea.
Topics: Acetylcholine; Antipsychotic Agents; Basal Ganglia; Cerebrovascular Disorders; Chorea; Diazepam; Dop | 1983 |
2 trials available for homovanillic acid and Chorea
| Article | Year |
|---|---|
Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
Topics: Aged; Antiparkinson Agents; Chorea; Clinical Trials as Topic; Confusion; Dioxoles; Dopamine; Drug Ev | 1975 |
Acute reduction and long-term improvement of chorea with ceruletide (cholecystokinin analogue).
Topics: Adult; Aged; Ceruletide; Cholecystokinin; Chorea; Dopamine; Drug Evaluation; Electromyography; Homov | 1990 |
18 other studies available for homovanillic acid and Chorea
| Article | Year |
|---|---|
Normal excretion of homovanillic acid in the urine of patients with Huntington's chorea.
Topics: Body Fluids; Chorea; Homovanillic Acid; Humans; Huntington Disease; Phenylacetates | 1961 |
Determination by thin-layer chromatography of urinary homovanillic acid in normal and disease states.
Topics: Chorea; Chromatography, Thin Layer; Ganglioneuroma; Hepatolenticular Degeneration; Homovanillic Acid | 1963 |
Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially.
Topics: Child; Chorea; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Aci | 1980 |
Isoniazid effects on choreiform movement and on GABA, HVA, and 5-HIAA in CSF.
Topics: Aged; Chorea; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1983 |
[Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
Topics: Acanthocytes; Adult; Aged; Atrophy; Brain Diseases; Chorea; gamma-Aminobutyric Acid; Homovanillic Ac | 1983 |
Homovanillic acid & 5-hydroxy indole acetic acid in the CSF in rheumatic chorea.
Topics: Adolescent; Adult; Child; Chorea; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 1983 |
Homovanilic acid in Huntington's disease and Sydenham's chorea.
Topics: Adult; Chorea; Female; Homovanillic Acid; Humans; Huntington Disease; Male; Middle Aged; Phenylaceta | 1981 |
[Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
Topics: Athetosis; Basal Ganglia Diseases; Chorea; Dopamine; Dystonia Musculorum Deformans; Homovanillic Aci | 1981 |
Letter: Amantadine in chorea.
Topics: Aged; Amantadine; Chorea; Drug Evaluation; Homovanillic Acid; Humans; Huntington Disease; Hydroxyind | 1975 |
Rational approaches to the pharmacotherapy of chorea.
Topics: Acetylcholine; Chorea; Dopamine; Drug Evaluation; gamma-Aminobutyric Acid; Homovanillic Acid; Humans | 1976 |
Abnormal excretion of phenolic acids in rheumatic chorea.
Topics: Acute Disease; Child; Chorea; Female; Homovanillic Acid; Humans; Male; Phenylacetates; Syndrome; Van | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; | 1977 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; | 1977 |
Sequential parkinsonism and chorea following "mild" inluenza.
Topics: Adolescent; Antibodies, Viral; Chorea; Homovanillic Acid; Humans; Influenza A virus; Influenza, Huma | 1976 |
Dopaminergic function in Gilles de la Tourette's syndrome, Sydenham's chorea and torsion dystonia.
Topics: Adolescent; Adult; Apomorphine; Child; Chorea; Dopamine; Dystonia Musculorum Deformans; Female; Halo | 1976 |
Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor.
Topics: Acute Disease; Adolescent; Carbidopa; Chorea; Drug Therapy, Combination; Homovanillic Acid; Humans; | 1975 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus | 1972 |
HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Chorea; Dopamine; Dystonia Musculorum Deformans; Femal | 1973 |